David A. Siegel Maravai Lifesciences Holdings, Inc. Transaction History
Two Sigma Advisers, LP
- $42.8 Billion
- Q1 2025
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 2,238,000 shares of MRVI stock, worth $5.66 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,238,000
Previous 216,500
933.72%
Holding current value
$5.66 Million
Previous $1.18 Million
319.42%
% of portfolio
0.01%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding MRVI
# of Institutions
198Shares Held
129MCall Options Held
267KPut Options Held
648K-
Gtcr LLC20.2MShares$51 Million4.99% of portfolio
-
12 West Capital Management LP New York, NY12.5MShares$31.7 Million4.53% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$29.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.73MShares$24.6 Million0.0% of portfolio
-
Braidwell LP Stamford, CT8.35MShares$21.1 Million1.13% of portfolio
About MARAVAI LIFESCIENCES HOLDINGS, INC.
- Ticker MRVI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 131,540,000
- Market Cap $333M
- Description
- Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...